Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

758

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

June 5, 2025

Study Completion Date

March 30, 2027

Conditions
Lung Cancer, Non-Small Cell
Interventions
BIOLOGICAL

Cobolimab

Cobolimab will be administered.

BIOLOGICAL

Dostarlimab

Dostarlimab will be administered.

DRUG

Docetaxel

Docetaxel will be administered.

Trial Locations (163)

1120

GSK Investigational Site, Adana

1425

GSK Investigational Site, Ciudad Autonoma de Buenos Aire

1602

GSK Investigational Site, Florida

3004

GSK Investigational Site, Melbourne

3350

GSK Investigational Site, Ballarat

GSK Investigational Site, Mount Waverley

3500

GSK Investigational Site, Hasselt

4101

GSK Investigational Site, South Brisbane

5037

GSK Investigational Site, Ashford

7000

GSK Investigational Site, Hobart

8500

GSK Investigational Site, Kortrijk

9300

GSK Investigational Site, Aalst

10016

GSK Investigational Site, New York

10043

GSK Investigational Site, Orbassano to

10300

GSK Investigational Site, Dusit

10408

GSK Investigational Site, Gyeonggi-do

10601

GSK Investigational Site, White Plains

11217

GSK Investigational Site, Taipei

11501

GSK Investigational Site, Mineola

11526

GSK Investigational Site, Athens

11528

GSK Investigational Site, Athens

12120

GSK Investigational Site, Pathum Thani

12200

GSK Investigational Site, Berlin

12462

GSK Investigational Site, Athens

13009

GSK Investigational Site, Marseille

13620

GSK Investigational Site, Seongnam-si Gyeonggi-do

15006

GSK Investigational Site, A Coruña

15224

GSK Investigational Site, Pittsburgh

15232

GSK Investigational Site, Pittsburgh

20132

GSK Investigational Site, Milan

20133

GSK Investigational Site, Milan

20422

GSK Investigational Site, Washington D.C.

20900

GSK Investigational Site, Monza

22408

GSK Investigational Site, Fredericksburg

26121

GSK Investigational Site, Oldenburg

26504

GSK Investigational Site, Rio Patras

28007

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28050

GSK Investigational Site, Madrid

28222

GSK Investigational Site, Madrid

28644

GSK Investigational Site, Cheongju Chungcheongbuk-do

29010

GSK Investigational Site, Málaga

29107

GSK Investigational Site, Quimper

35016

GSK Investigational Site, Las Palmas de Gran Canar

35033

GSK Investigational Site, Rennes

35600

GSK Investigational Site, Izmir

37044

GSK Investigational Site, Tours

38043

GSK Investigational Site, Grenoble

40002

GSK Investigational Site, Khon Kaen

41017

GSK Investigational Site, Edgewood

41100

GSK Investigational Site, Larissa

42601

GSK Investigational Site, Daegu

44280

GSK Investigational Site, Guadalajara

45147

GSK Investigational Site, Essen

46026

GSK Investigational Site, Valencia

49241

GSK Investigational Site, Pusan

50134

GSK Investigational Site, Florence

51109

GSK Investigational Site, Cologne

52242

GSK Investigational Site, Iowa City

53100

GSK Investigational Site, Siena

53113

GSK Investigational Site, Bonn

55236

GSK Investigational Site, Thessaloniki

57010

GSK Investigational Site, Thessaloniki

57105

GSK Investigational Site, Sioux Falls

60126

GSK Investigational Site, Ancona

60488

GSK Investigational Site, Frankfurt

60590

GSK Investigational Site, Frankfurt

64460

GSK Investigational Site, Monterrey

69126

GSK Investigational Site, Heidelberg

70210

GSK Investigational Site, Kuopio

72560

GSK Investigational Site, Puebla Puebla

76137

GSK Investigational Site, Karlsruhe

77030

GSK Investigational Site, Houston

80131

GSK Investigational Site, Napoli

80336

GSK Investigational Site, München

81925

GSK Investigational Site, München

83100

GSK Investigational Site, Avellino

86156

GSK Investigational Site, Augsburg

89144

GSK Investigational Site, Las Vegas

90110

GSK Investigational Site, Kho Hong Hat Yai

92708

GSK Investigational Site, Fountain Valley

94010

GSK Investigational Site, Créteil

94596

GSK Investigational Site, Walnut Creek

96819

GSK Investigational Site, Honolulu

98405

GSK Investigational Site, Tacoma

99437

GSK Investigational Site, Bad Berka

140044

GSK Investigational Site, Córdoba

143423

GSK Investigational Site, Moscow Region

196603

GSK Investigational Site, Pushkin

197022

GSK Investigational Site, Saint Petersburg

200347

GSK Investigational Site, Craiova

200385

GSK Investigational Site, Craiova Dolj

300239

GSK Investigational Site, Timișoara

454048

GSK Investigational Site, Chelyabinsk

22061080

GSK Investigational Site, Rio de Janeiro

89010340

GSK Investigational Site, Blumenau

90610000

GSK Investigational Site, Porto Alegre

06360

GSK Investigational Site, Norwich

C1426ABP

GSK Investigational Site, Buenos Aires

R8324CVE

GSK Investigational Site, Cipoletti Rio Negro

F5300COE

GSK Investigational Site, La Rioja

B2700CPM

GSK Investigational Site, Pergamino

S2000DBS

GSK Investigational Site, Rosario

R8500ACE

GSK Investigational Site, Viedma

60336-232

GSK Investigational Site, Fortaleza

22250-905

GSK Investigational Site, Rio de Janeiro

40170-110

GSK Investigational Site, Salvador

04014-002

GSK Investigational Site, São Paulo

P3E 5J1

GSK Investigational Site, Greater Sudbury

K7L 2V7

GSK Investigational Site, Kingston

L1G 2B9

GSK Investigational Site, Oshawa

J4V 2H1

GSK Investigational Site, Greenfield Park

H3T 1E2

GSK Investigational Site, Montreal

00180

GSK Investigational Site, Helsinki

06189

GSK Investigational Site, Nice

01307

GSK Investigational Site, Dresden

06120

GSK Investigational Site, Halle

115 27

GSK Investigational Site, Athens

570 01

GSK Investigational Site, Pylaia Thessaloniki

06156

GSK Investigational Site, Perugia

612-8555

GSK Investigational Site, Kyoto

981-1293

GSK Investigational Site, Miyagi

591-8555

GSK Investigational Site, Osaka

755-0241

GSK Investigational Site, Yamaguchi

03100

GSK Investigational Site, Mexico City

03810

GSK Investigational Site, Mexico City

06700

GSK Investigational Site, Mexico City

CP 14080

GSK Investigational Site, Mexico City

3813 TZ

GSK Investigational Site, Amersfoort

7512 KZ

GSK Investigational Site, Enschede

9713 GZ

GSK Investigational Site, Groningen

3844 DG

GSK Investigational Site, Harderwijk

6525 GA

GSK Investigational Site, Nijmegen

3543 AZ

GSK Investigational Site, Utrecht

8025 AB

GSK Investigational Site, Zwolle

85-796

GSK Investigational Site, Bydgoszcz

81-519

GSK Investigational Site, Gdynia

90-338

GSK Investigational Site, Lodz

10-357

GSK Investigational Site, Olsztyn

64-920

GSK Investigational Site, Piła

60-693

GSK Investigational Site, Poznan

013812

GSK Investigational Site, Bucharest

075100

GSK Investigational Site, Otopeni

03722

GSK Investigational Site, Seoul

05505

GSK Investigational Site, Seoul

06351

GSK Investigational Site, Seoul

08308

GSK Investigational Site, Seoul

443-721

GSK Investigational Site, Suwon Kyunggi-do

08916

GSK Investigational Site, Badalona

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

09006

GSK Investigational Site, Burgos

SE-801 87

GSK Investigational Site, Gävle

171 64

GSK Investigational Site, Stockholm

SE-751 85

GSK Investigational Site, Uppsala

07020

GSK Investigational Site, Antalya

CF14 2TL

GSK Investigational Site, Cardiff

EH4 2XU

GSK Investigational Site, Edinburgh

SE1 9RT

GSK Investigational Site, London

W1G 6AD

GSK Investigational Site, London

M20 4BX

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04655976 - Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy | Biotech Hunter | Biotech Hunter